Volume 16 Issue 1 - International Pharmaceutical Industry

Current Edition

Volume 16 Issue 1

Revolutionising Pharmaceutical Logistics: The Path to Sustainable Cooling Solutions

The healthcare industry is at a pivotal moment in its journey toward sustainability, as the demand for efficient cold chain management in transporting and storing me...

1 October 2024 Volume 16 Issue 1 | Editorial Archive

Continue Reading →

Volume 16 Issue 1

Harnessing The Power of Solid Form and Particle Engineering to Overcome Solubility and Bioavailability Challenges

An Interview with Veranova’s Craig Grant Persistent challenges in poor solubility and low bioavailability have long impeded the pharmaceutical development pipelin...

15 April 2024 Volume 16 Issue 1 | Editorial Archive Bioavailability | companies

Continue Reading →

Volume 16 Issue 1

Navigating the 2024 Life Science Landscape: Trends, Challenges, and Opportunities

As we step into 2024, the global life science industry finds itself at a crossroads, facing plenty of challenges alongside an abundance of exciting opportunities. ...

15 April 2024 Volume 16 Issue 1 | Editorial Archive challenges | contract

Continue Reading →

Volume 16 Issue 1

Proposed March-in Guidance Signals Funding Agencies to Actively Evaluate Government Rights Under the Bayh-dole Act

The Bayh-Dole Act (“Bayh-Dole”) governs the rights to inventions made with federal assistance. It offers ownership rights to federal award recipients (“Contractors”)...

15 April 2024 Volume 16 Issue 1 | Editorial Archive Agencies | assistance

Continue Reading →

Volume 16 Issue 1

Updating Your Regulatory Information Management Capability? It Could Pay to Get Hands-on

Letting business-savvy techies play around with a new RIM system ahead of the proposed implementation could save Life Sciences companies a fortune, says Romuald Brau...

15 April 2024 Volume 16 Issue 1 | Editorial Archive brand | Capability

Continue Reading →

Volume 16 Issue 1

The Delivery of Pharmaceutical Drugs and How it Will Change the Future

Pharmaceutical drugs have seen a seismic shift over the past ten years, moving away from chemically synthesised drugs to focus more on a new class of biological drug...

15 April 2024 Volume 16 Issue 1 | Editorial Archive change | chemically

Continue Reading →

Volume 16 Issue 1

Exploring Device Interchangeability for Drug Deliver

Alex Fong, Head of Insight, Owen Mumford Pharmaceutical Services Devices as Differentiators Choosing the right injectable drug delivery device can be a crucial...

15 April 2024 Volume 16 Issue 1 | Sponsored Articles

Continue Reading →

Volume 16 Issue 1

Big Data, Personalised Medicine and Support for Healthcare Professionals

What Will Drive Pharma in 2024? In 2023, precision targeting for personalised medicines, improving the information flow between reps and healthcare professionals,...

15 April 2024 Volume 16 Issue 1 | Editorial Archive adoption | Advancements

Continue Reading →

Volume 16 Issue 1

Novel Drugs: Challenging Entrenched Prescriber/Investment Behaviour is not Just About Education

Behavioural science’s time has come in the pharma industry, as medical communications adapt to a more ambitious and diverse treatment landscape. Drawing on examples ...

15 April 2024 Volume 16 Issue 1 | Editorial Archive adapt | Challenging

Continue Reading →

Volume 16 Issue 1

Transforming the Biologics Product Lifecycle with Inhalation Innovation

In recent years, the biopharmaceuticals landscape has witnessed a revolutionary shift with the emergence of new nasal inhalation technologies. Among these, soft mist...

15 April 2024 Volume 16 Issue 1 | Editorial Archive biologics | delivery

Continue Reading →

Christ Packaging Systems – Large-format Pouches in the Medical Device and Pharmaceutical Industry

SCHOTT Pharma

Integrated Product Development by PharmaLex

It’s All About Stem Cells

Covid 19

Current Edition

Revolutionising Pharmaceutical Logistics: The Path to Sustainable Cooling Solutions

Harnessing The Power of Solid Form and Particle Engineering to Overcome Solubility and Bioavailability Challenges

Navigating the 2024 Life Science Landscape: Trends, Challenges, and Opportunities

Proposed March-in Guidance Signals Funding Agencies to Actively Evaluate Government Rights Under the Bayh-dole Act

Updating Your Regulatory Information Management Capability? It Could Pay to Get Hands-on

The Delivery of Pharmaceutical Drugs and How it Will Change the Future

Exploring Device Interchangeability for Drug Deliver

Big Data, Personalised Medicine and Support for Healthcare Professionals

Novel Drugs: Challenging Entrenched Prescriber/Investment Behaviour is not Just About Education

Transforming the Biologics Product Lifecycle with Inhalation Innovation

International Pharmaceutical Industry